Atropos Health study reveals 97% of AUD patients miss medication
The study, powered by Atropos platform, analyzed 7,560 patients and found only 3% received medication, indicating a critical care gap.
See the latest news and media coverage for Atropos Health. We track all announcements, press releases, and industry mentions in real time, all in one place.
Real-world evidence generation platform
atroposhealth.comLast updated
In short: Atropos Health raised $33M and launched the Alexandria library, the world's largest body of medical evidence, to scale its AI solutions.
The study, powered by Atropos platform, analyzed 7,560 patients and found only 3% received medication, indicating a critical care gap.
Study presented at ENDO2026 found semaglutide reduced fracture risk by 15% in type 2 diabetes patients.
It combines predictive modeling and evidence generation to embed insights into the electronic health record.
Research uses Atropos Evidence™ Network data to evaluate liver safety, suggesting promising therapeutic approach. Authors include Atropos Health and Stanford experts.
The Company is Also Forging Strategic Partnerships With Pharmaceutical Companies and Vertically Integrated Healthcare Companies to Drive Evidence Adoption in Oncology and other Specialty areas...
Atropos Health launches medical evidence library to support clinical decisions and integrate with systems used by Meta, Microsoft, and health systems.
Alexandria now includes 33M precision Evidence-Based Findings (pEBF(TM)) growing to more than two billion studies in 2026, exceeding evidence-based findings in all public medical literature...
Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE) for clinical decision making, today announced a scientific, multi-layered process for...
Track Atropos Health and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Atropos Health and other trending companies.